![Shu Kam Mok](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shu Kam Mok
Directeur/Membre du Conseil chez
ASTRAZENECA PLC
Fortune : 970 704 $ au 31/05/2026
Profil
Shu Kam Mok was the founder of Sanomics Ltd. founded in 2015, holding the title of Chairman.
Dr. Mok is also the founder of Chinese Thoracic Oncology Group,Asia Thoracic Oncology Research Group,Aurora Tele-Oncology Ltd...
Dr. Mok currently serves as Independent Non-Executive Director at AstraZeneca PLC since 2019, Non-Executive Independent Director at Lunit Usa, Inc., Director at Insighta Ltd., and Secretary at the Chinese Society of Clinical Oncology.
Former positions include Chairman-Clinical Oncology Department at The Chinese University of Hong Kong, Chairman at ACT Genomics Co. Ltd., Lead Independent Non-Executive Director at HUTCHMED (China) Ltd. from 2025 to 2026, Director at American Society of Clinical Oncology, Inc., and Treasurer at the International Association for the Study of Lung Cancer.
Education includes undergraduate and doctorate degrees from the University of Alberta.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 3 500 ( 0 % ) | 651 154 $ | 31/05/2026 | |
HUTCHMED (CHINA) LIMITED 0,02 % | 12/05/2026 | 136 705 ( 0,02 % ) | 319 549 $ | 31/05/2026 |
Postes actifs de Shu Kam Mok
| Sociétés | Poste | Début |
|---|---|---|
| ASTRAZENECA PLC | Directeur/Membre du Conseil | 01/01/2019 |
Chinese Society of Clinical Oncology | Secrétaire Général | - |
Lunit Usa, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Shu Kam Mok
| Sociétés | Poste | Fin |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Directeur/Membre du Conseil | 12/05/2026 |
ACT Genomics Co. Ltd.
 ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Président | 01/01/2022 |
Aurora Tele-Oncology Ltd.
 Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Operates an oncology-specific teleconsultation platform striving to improve cancer care | Fondateur | - |
Chinese Thoracic Oncology Group | Fondateur | - |
Asia Thoracic Oncology Research Group | Fondateur | - |
Formation de Shu Kam Mok
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
HUTCHMED (China) Ltd.
 HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
International Association for the Study of Lung Cancer
 International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Commercial Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
Chinese Society of Clinical Oncology | |
Sanomics Ltd.
 Sanomics Ltd. Miscellaneous Commercial ServicesCommercial Services Specializes in blood-based genomics technologies for cancer patients | Commercial Services |
Chinese Thoracic Oncology Group | |
Asia Thoracic Oncology Research Group | |
Aurora Tele-Oncology Ltd.
Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Operates an oncology-specific teleconsultation platform striving to improve cancer care | Health Services |
Lunit Usa, Inc. |
